These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38838321)

  • 1. Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria. Reply.
    Risitano AM; Kulasekararaj AG; Peffault de Latour R
    N Engl J Med; 2024 Jun; 390(21):2033-2034. PubMed ID: 38838321
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria.
    Marnas P; Zarogiannis SG
    N Engl J Med; 2024 Jun; 390(21):2033. PubMed ID: 38838320
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria.
    Hillmen P
    N Engl J Med; 2024 Jun; 390(21):2032-2033. PubMed ID: 38838319
    [No Abstract]   [Full Text] [Related]  

  • 4. Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial.
    Risitano AM; Röth A; Soret J; Frieri C; de Fontbrune FS; Marano L; Alashkar F; Benajiba L; Marotta S; Rozenberg I; Milojevic J; End P; Nidamarthy PK; Junge G; Peffault de Latour R
    Lancet Haematol; 2021 May; 8(5):e344-e354. PubMed ID: 33765419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eculizumab (Soliris) for paroxysmal nocturnal hemoglobinuria.
    Med Lett Drugs Ther; 2007 Sep; 49(1270):79-80. PubMed ID: 17878890
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria.
    Peffault de Latour R; Röth A; Kulasekararaj AG; Han B; Scheinberg P; Maciejewski JP; Ueda Y; de Castro CM; Di Bona E; Fu R; Zhang L; Griffin M; Langemeijer SMC; Panse J; Schrezenmeier H; Barcellini W; Mauad VAQ; Schafhausen P; Tavitian S; Beggiato E; Chew LP; Gaya A; Huang WH; Jang JH; Kitawaki T; Kutlar A; Notaro R; Pullarkat V; Schubert J; Terriou L; Uchiyama M; Wong Lee Lee L; Yap ES; Sicre de Fontbrune F; Marano L; Alashkar F; Gandhi S; Trikha R; Yang C; Liu H; Kelly RJ; Höchsmann B; Kerloeguen C; Banerjee P; Levitch R; Kumar R; Wang Z; Thorburn C; Maitra S; Li S; Verles A; Dahlke M; Risitano AM
    N Engl J Med; 2024 Mar; 390(11):994-1008. PubMed ID: 38477987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria.
    Xu B; Kang B; Chen J; Li S; Zhou J
    Blood Rev; 2024 Jul; 66():101210. PubMed ID: 38811284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria.
    Tomita A; Shirasugi Y; Ito T; Tsurumi H; Naoe T
    Ann Hematol; 2012 Jul; 91(7):1139-41. PubMed ID: 22080148
    [No Abstract]   [Full Text] [Related]  

  • 9. Iptacopan (Fabhalta) for paroxysmal nocturnal hemoglobinuria.
    Med Lett Drugs Ther; 2024 Sep; 66(1712):e171-e173. PubMed ID: 39302352
    [No Abstract]   [Full Text] [Related]  

  • 10. General anesthesia for cesarean delivery in a patient with paroxysmal nocturnal hemoglobinuria and thrombocytopenia.
    Kjaer K; Comerford M; Gadalla F
    Anesth Analg; 2004 May; 98(5):1471-2, table of contents. PubMed ID: 15105233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drugs: ambrisentan, temsirolimus, and eculizumab.
    Hussar DA
    J Am Pharm Assoc (2003); 2007; 47(5):664, 666-7, 669-71. PubMed ID: 17848357
    [No Abstract]   [Full Text] [Related]  

  • 12. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
    Yuan X; Gavriilaki E; Thanassi JA; Yang G; Baines AC; Podos SD; Huang Y; Huang M; Brodsky RA
    Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuria.
    Fahim SM; Makam AN; Suh K; Carlson JJ; Richardson M; Herce-Hagiwara B; Dickerson R; Pearson SD; Agboola F
    J Manag Care Spec Pharm; 2024 Jun; 30(6):618-623. PubMed ID: 38824627
    [No Abstract]   [Full Text] [Related]  

  • 14. The first successful expanded compassionate use of Iptacopan in a patient with paroxysmal nocturnal hemoglobinuria.
    Han B; Ji J; Zhang B; Bai H; Zhou D; Feng F; Huang Y; Zhu H; Chen L; Wu Z; Jiang X; Li X; Jia Q; Chang Q; Pan H; Peng H; Zheng W; Huang H; Chen Z; Yang C; Chen M; Du B; Zhang S
    Ann Hematol; 2022 Nov; 101(11):2537-2539. PubMed ID: 35965286
    [No Abstract]   [Full Text] [Related]  

  • 15. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Takita M; Matsumura T; Kami M
    N Engl J Med; 2006 Dec; 355(26):2787; author reply 2787-8. PubMed ID: 17193722
    [No Abstract]   [Full Text] [Related]  

  • 16. 60-Year-Old Woman With Headache and Fatigue.
    Cornell LF; Sacco KA; Chirila RM
    Mayo Clin Proc; 2017 Sep; 92(9):e121-e125. PubMed ID: 28693745
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebral sinus thrombosis and heparin-induced thrombocytopenia in a patient with paroxysmal nocturnal hemoglobinuria.
    Ishihara-Kawase K; Ohtsuki T; Sugihara S; Tanaka H; Nakamura T; Kimura A; Matsumoto M
    Intern Med; 2010; 49(10):941-3. PubMed ID: 20467181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study.
    Jang JH; Wong L; Ko BS; Yoon SS; Li K; Baltcheva I; Nidamarthy PK; Chawla R; Junge G; Yap ES
    Blood Adv; 2022 Aug; 6(15):4450-4460. PubMed ID: 35561315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria.
    Tsai CW; Wu VC; Lin WC; Huang JW; Wu MS
    Kidney Int; 2007 Jun; 71(11):1187. PubMed ID: 17522699
    [No Abstract]   [Full Text] [Related]  

  • 20. [Paroxysmal nocturnal hemoglobinuria].
    Geffray L
    Rev Med Interne; 2008 Nov; 29(11):957-61. PubMed ID: 18801601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.